Privia Health price target raised to $29 from $26 at Citizens JMP

Citizens JMP raised the firm’s price target on Privia Health (PRVA) to $29 from $26 and keeps an Outperform rating on the shares. Privia Health’s key operating and financial metrics for Q4 beat the firm’s projections, the analyst tells investors in a research note. The firm views recent actions by other value-based care entities to implement a more measured philosophy toward risk, together with Privia’s consistent execution, as further validation of Privia’s approach.